CapsoVision, Inc. (CV)
Nasdaq: CV · Electromedical & Electrotherapeutic Apparatus · Saratoga, CA · filing with the SEC since 2006
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 26, 2026 | · |
| Revenue | 13,554 | 11,756 |
| Cost of revenue | 6,381 | 5,379 |
| Gross profit | 7,173 | 6,377 |
| Research and development | 18,310 | 15,120 |
| Sales and marketing | 7,530 | 6,967 |
| General and administrative | 6,849 | 4,207 |
| Total operating expenses | 32,689 | 26,294 |
| Operating income | -25,516 | -19,917 |
| Interest and investment income | 269 | 26 |
| Other income (expense), net | -44 | 4 |
| Total non-operating income (expense) | 225 | 30 |
| Income before income taxes | -25,291 | -19,887 |
| Income tax expense | 24 | 11 |
| Net income | -25,315 | -19,898 |
| Net income to common shareholders | -25,315 | -19,898 |
| Earnings per share, basic | -1.03 | -9.85 |
| Earnings per share, diluted | -1.03 | -9.85 |
| Weighted average shares, basic | 24,555,381 | 2,020,077 |
| Weighted average shares, diluted | 24,555,381 | 2,020,077 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding